542 related articles for article (PubMed ID: 10353744)
41. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
Hoon DS; Bostick P; Kuo C; Okamoto T; Wang HJ; Elashoff R; Morton DL
Cancer Res; 2000 Apr; 60(8):2253-7. PubMed ID: 10786692
[TBL] [Abstract][Full Text] [Related]
42. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
43. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Kusić Z
Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
[TBL] [Abstract][Full Text] [Related]
44. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
45. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Tsao H; Nadiminti U; Sober AJ; Bigby M
Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
[TBL] [Abstract][Full Text] [Related]
46. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
47. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
48. Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood.
Suárez A; Fra J; Alonso R; Sánchez R; Lacave AJ; Gutiérrez C
Anticancer Res; 2002; 22(2B):1091-5. PubMed ID: 12168906
[TBL] [Abstract][Full Text] [Related]
49. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
[TBL] [Abstract][Full Text] [Related]
50. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
Tessier MH; Denis MG; Lustenberger P; Dreno B
Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
[TBL] [Abstract][Full Text] [Related]
51. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
[TBL] [Abstract][Full Text] [Related]
52. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
[TBL] [Abstract][Full Text] [Related]
54. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
Ko Y; Klinz M; Totzke G; Gouni-Berthold I; Sachinidis A; Vetter H
Clin Cancer Res; 1998 Sep; 4(9):2141-6. PubMed ID: 9748132
[TBL] [Abstract][Full Text] [Related]
55. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Kuo CT; Bostick PJ; Irie RF; Morton DL; Conrad AJ; Hoon DS
Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930
[TBL] [Abstract][Full Text] [Related]
56. [Detection of cytokeratin20 mRNA in peripheral blood from colonic cancer patients by fluorescence quantitative polymerase chain reaction].
Wang ZC; Wang C; Zeng QG
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):600-3. PubMed ID: 18210880
[TBL] [Abstract][Full Text] [Related]
57. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
58. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
[TBL] [Abstract][Full Text] [Related]
59. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
Müller C; Petermann D; Pfeffel F; Oesterreicher C; Függer R
Hepatology; 1997 Apr; 25(4):896-9. PubMed ID: 9096594
[TBL] [Abstract][Full Text] [Related]
60. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
